Back to search results

High Intensity Focused Electromagnetic Stimulation for Fecal Incontinence in Ulcerative Colitis Patients with J-Pouch

This study is looking at how a treatment called High Intensity Focused Electromagnetic Stimulation (using a device called the Emsella chair) affects people with Ulcerative Colitis or IBDU who have had J-pouch surgery and experience fecal incontinence. The goal is to see if this treatment can improve your quality of life. You can join if you are 18 or older, had J-pouch surgery at least one year ago due to Ulcerative Colitis or IBDU, and have fecal incontinence. The study will measure changes in your overall quality of life using a special questionnaire at the beginning, one month, and three months after treatment. The current status of this study is unclear, and it plans to enroll 20 participants.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 20 participants.
What's involved
Participants will sit on the High Intensity Focused Electromagnetic Stimulation device for 28 minutes, twice a week for three weeks.
Compensation
Not stated in the trial record.
Follow-up
Your quality of life will be checked at one month and three months after the treatment begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07034443

Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation

Recruiting
NAAges 18+InterventionalTreatment
Cedars-Sinai Medical Center
~20 participants
Updated 2026-08-12 on ClinicalTrials.gov
What's tested:High Intensity Focused Electromagnetic Stimulation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Determine if patients have change in overall quality of live, as determined by statistically significant change in Patient Reported Outcomes Measurement Information System 10 Score from baseline
Measured over baseline, 1 month and 3 months

Conditions

Fecal Incontinence

Explore related trials

Inflammatory Bowel Disease UnclassifiedUlcerative Colitis

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Karen Zaghiyan, MD · PRINCIPAL_INVESTIGATOR · Cedar Sinai Medical Center

Who to contact

Samara Spence, MD
[email protected]
6037323655
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Individuals 18 years old or older are included.
Patients who have a J pouch reconstruction due to Ulcerative Colitis or IBDU
Must be at least 1 year out from J pouch surgery
Have fecal incontinence

Exclusion

Any records flagged "break the glass" or "research opt out."
Pediatric Patients \<18 years of age
Did not receive a J pouch
Patients who received a J pouch for any other indication, including but not limited to Crohn's disease, familial adenosis polyposis
Have active pouchitis
Have an active fistula
If reclassified to de novo Crohn's after surgery
Have implanted metal devices or medical devices
Pregnant patients

What this trial measures

  • Determine if patients have change in overall quality of live, as determined by statistically significant change in Patient Reported Outcomes Measurement Information System 10 Score from baselinebaseline, 1 month and 3 months

    Patient Reported Outcomes Measurement Information System Score (PROMIS 10), scaled from 0-20 evaluate patient overall quality of life. Higher score indicates better health